Live and heat-killed probiotic Lactobacillus casei Lbs2 protects from experimental colitis through Toll-like receptor 2-dependent induction of T-regulatory response

International Immunopharmacology

Volumn 36, Issue , 2016, Pages 39-50

  Thakur, Bhupesh Kumar ^a   Saha, Piu ^a   Banik, George ^b   Saha, Dhira Rani ^a   Grover, Sunita ^c   Batish, Virender Kumar ^c   Das, Santasabuj ^a  

^a NATIONAL INSTITUTE OF CHOLERA AND ENTERIC DISEASES   (India)

^b BD Biosciences   (India)

^c NATIONAL DAIRY RESEARCH INSTITUTE   (India)

Author keywords

Immunomodulation; Inflammatory bowel disease; Lactobacillus; Probiotics; Regulatory T cells; Toll like receptor

Indexed keywords

CD103 ANTIGEN; CD4 ANTIGEN; DNA 16S; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 17; INTERLEUKIN 6; L SELECTIN; LIPOPOLYSACCHARIDE; MYELOPEROXIDASE; PROBIOTIC AGENT; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 9; TRANSCRIPTION FACTOR FOXP3; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA; VSL3; AUTACOID; CYTOKINE; FORKHEAD TRANSCRIPTION FACTOR; FOXP3 PROTEIN, MOUSE; TLR2 PROTEIN, MOUSE; TRINITROBENZENESULFONIC ACID;

ADAPTIVE IMMUNITY; ADOPTIVE TRANSFER; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATE; CELL INFILTRATION; CELL PROLIFERATION; CONTROLLED STUDY; CYTOKINE RELEASE; DENDRITIC CELL; DISEASE SEVERITY; EXPERIMENTAL COLITIS; FLOW CYTOMETRY; GOBLET CELL; HISTOPATHOLOGY; HYPEREMIA; INFLAMMATORY CELL; INTESTINE ULCER; LACTOBACILLUS CASEI; LACTOBACILLUS CASEI LBS2; LACTOBACILLUS RHAMNOSUS; LIPOPOLYSACCHARIDE-INDUCED SEPSIS; MALE; MESENTERY LYMPH NODE; MOUSE; NONHUMAN; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; SUPPRESSOR CELL; TH0 CELL; ANIMAL; BAGG ALBINO MOUSE; CELL CULTURE; CHEMICALLY INDUCED; COLITIS; DISEASE MODEL; DRUG EFFECTS; HEAT; HUMAN; IMMUNOLOGY; IMMUNOSUPPRESSIVE TREATMENT; IMMUNOTHERAPY; INTESTINE MUCOSA; METABOLISM; PROCEDURES; TRANSPLANTATION;

ANIMALS; CELLS, CULTURED; COLITIS; CYTOKINES; DENDRITIC CELLS; DISEASE MODELS, ANIMAL; FORKHEAD TRANSCRIPTION FACTORS; HOT TEMPERATURE; HUMANS; IMMUNOSUPPRESSION; IMMUNOTHERAPY; INFLAMMATION MEDIATORS; INTESTINAL MUCOSA; LACTOBACILLUS CASEI; MALE; MICE; MICE, INBRED BALB C; PROBIOTICS; T-LYMPHOCYTES, REGULATORY; TOLL-LIKE RECEPTOR 2; TRINITROBENZENESULFONIC ACID;

EID: 84964339327     PISSN: 15675769     EISSN: 18781705     Source Type: Journal    
DOI: 10.1016/j.intimp.2016.03.033     Document Type: Article

References (61)

1. M.J. Saez-Lara, C. Gomez-Llorente, J. Plaza-Diaz, and A. Gil The role of probiotic lactic acid bacteria and bifidobacteria in the prevention and treatment of inflammatory bowel disease and other related diseases: a systematic review of randomized human clinical trials BioMed Research International 2015 2015 505878
2. C.N. Bernstein Treatment of IBD: where we are and where we are going Am. J. Gastroenterol. 110 2015 114 126
3. R. Orel, and Trop T. Kamhi Intestinal microbiota, probiotics and prebiotics in inflammatory bowel disease World journal of gastroenterology: WJG. 20 2014 11505 11524
4. I. Dotan, and D. Rachmilewitz Probiotics in inflammatory bowel disease: possible mechanisms of action Curr. Opin. Gastroenterol. 21 2005 426 430
5. Celiberto LS, Bedani R, Rossi EA, Cavallini DC. Probiotics: the scientific evidence in the context of inflammatory bowel disease. Crit. Rev. Food Sci. Nutr. 2015:0.
6. S. Grover, H.M. Rashmi, A.K. Srivastava, and V.K. Batish Probiotics for human health - new innovations and emerging trends Gut Pathogens 4 2012 15
7. I.C. Lee, S. Tomita, M. Kleerebezem, and P.A. Bron The quest for probiotic effector molecules - unraveling strain specificity at the molecular level Pharmacological Research: The Official Journal of the Italian Pharmacological Society 69 2013 61 74
8. V. Taverniti, and S. Guglielmetti The immunomodulatory properties of probiotic microorganisms beyond their viability (ghost probiotics: proposal of paraprobiotic concept) Genes & Nutrition 6 2011 261 274
9. S.R. Dalal, and E.B. Chang The microbial basis of inflammatory bowel diseases J. Clin. Invest. 124 2014 4190 4196
10. M.F. Neurath Cytokines in inflammatory bowel disease Nat. Rev. Immunol. 14 2014 329 342
11. M. Fakhoury, R. Negrulj, A. Mooranian, and H. Al-Salami Inflammatory bowel disease: clinical aspects and treatments J. Inflamm. Res. 7 2014 113 120
12. K.J. Maloy, and F. Powrie Intestinal homeostasis and its breakdown in inflammatory bowel disease Nature 474 2011 298 306
13. D.C. Baumgart, and W.J. Sandborn Crohn's disease Lancet 380 2012 1590 1605
14. C. Becker, M.C. Fantini, C. Schramm, H.A. Lehr, S. Wirtz, A. Nikolaev, and et al. TGF-beta suppresses tumor progression in colon cancer by inhibition of IL-6 trans-signaling Immunity 21 2004 491 501
15. H.H. Uhlig, B.S. McKenzie, S. Hue, C. Thompson, B. Joyce-Shaikh, R. Stepankova, and et al. Differential activity of IL-12 and IL-23 in mucosal and systemic innate immune pathology Immunity 25 2006 309 318
16. E. Owaga, R.H. Hsieh, B. Mugendi, S. Masuku, C.K. Shih, and J.S. Chang Th17 cells as potential probiotic therapeutic targets in inflammatory bowel diseases Int. J. Mol. Sci. 16 2015 20841 20858
17. S. Issazadeh-Navikas, R. Teimer, and R. Bockermann Influence of dietary components on regulatory T cells Mol. Med. 18 2012 95 110
18. S. Bhowmick, M. Malar, A. Das, B. Kumar Thakur, P. Saha, S. Das, and et al. Draft genome sequence of Lactobacillus casei Lbs2 Genome Announcements 2 2014
19. S. Wirtz, C. Neufert, B. Weigmann, and M.F. Neurath Chemically induced mouse models of intestinal inflammation Nat. Protoc. 2 2007 541 546
20. M.B. Lutz, N. Kukutsch, A.L. Ogilvie, S. Rossner, F. Koch, N. Romani, and et al. An advanced culture method for generating large quantities of highly pure dendritic cells from mouse bone marrow J. Immunol. Methods 223 1999 77 92
21. J.L. Wallace, W.K. MacNaughton, G.P. Morris, and P.L. Beck Inhibition of leukotriene synthesis markedly accelerates healing in a rat model of inflammatory bowel disease Gastroenterology 96 1989 29 36
22. C.K. Ameho, A.A. Adjei, E.K. Harrison, K. Takeshita, T. Morioka, Y. Arakaki, and et al. Prophylactic effect of dietary glutamine supplementation on interleukin 8 and tumour necrosis factor alpha production in trinitrobenzene sulphonic acid induced colitis Gut 41 1997 487 493
23. P. Pandiyan, L. Zheng, S. Ishihara, J. Reed, and M.J. Lenardo CD4 + CD25 + Foxp3 + regulatory T cells induce cytokine deprivation-mediated apoptosis of effector CD4 + T cells Nat. Immunol. 8 2007 1353 1362
24. K. Gao, C. Wang, L. Liu, X. Dou, J. Liu, L. Yuan, and et al. Immunomodulation and signaling mechanism of Lactobacillus rhamnosus GG and its components on porcine intestinal epithelial cells stimulated by lipopolysaccharide Journal of Microbiology, Immunology, and Infection = Wei mian yu gan ran za zhi 2015
25. N. Li, W.M. Russell, M. Douglas-escobar, N. Hauser, M. Lopez, and J. Neu Live and heat-killed Lactobacillus rhamnosus GG: effects on proinflammatory and anti-inflammatory cytokines/chemokines in gastrostomy-fed infant rats Pediatr. Res. 66 2009 203 207
26. C.Y. Chung, D. Ysebaert, Z.N. Berneman, and N. Cools Dendritic cells: cellular mediators for immunological tolerance Clin. Dev. Immunol. 2013 2013 972865
27. C.G. Mayne, and C.B. Williams Induced and natural regulatory T cells in the development of inflammatory bowel disease Inflamm. Bowel Dis. 19 2013 1772 1788
28. C. Mottet, H.H. Uhlig, and F. Powrie Cutting edge: cure of colitis by CD4 + CD25 + regulatory T cells J. Immunol. 170 2003 3939 3943
29. F. Powrie, M.W. Leach, S. Mauze, L.B. Caddle, and R.L. Coffman Phenotypically distinct subsets of CD4 + T cells induce or protect from chronic intestinal inflammation in C. B-17 scid mice Int. Immunol. 5 1993 1461 1471
30. S. Lebeer, J. Vanderleyden, and S.C. De Keersmaecker Host interactions of probiotic bacterial surface molecules: comparison with commensals and pathogens Nat. Rev. Microbiol. 8 2010 171 184
31. C. Gomez-Llorente, S. Munoz, and A. Gil Role of Toll-like receptors in the development of immunotolerance mediated by probiotics The Proceedings of the Nutrition Society. 69 2010 381 389
32. B. Khor, A. Gardet, and R.J. Xavier Genetics and pathogenesis of inflammatory bowel disease Nature 474 2011 307 317
33. L. Halme, P. Paavola-Sakki, U. Turunen, M. Lappalainen, M. Farkkila, and K. Kontula Family and twin studies in inflammatory bowel disease World J. Gastroenterol. 12 2006 3668 3672
34. V. Valatas, G. Bamias, and G. Kolios Experimental colitis models: insights into the pathogenesis of inflammatory bowel disease and translational issues Eur. J. Pharmacol. 759 2015 253 264
35. M.F. Neurath, I. Fuss, B.L. Kelsall, E. Stuber, and W. Strober Antibodies to interleukin 12 abrogate established experimental colitis in mice J. Exp. Med. 182 1995 1281 1290
36. A.A. te Velde, M.I. Verstege, and D.W. Hommes Critical appraisal of the current practice in murine TNBS-induced colitis Inflamm. Bowel Dis. 12 2006 995 999
37. L.X. Sang, B. Chang, B.Y. Wang, W.X. Liu, and M. Jiang Live and heat-killed probiotic: effects on chronic experimental colitis induced by dextran sulfate sodium (DSS) in rats Int. J. Clin. Exp. Med. 8 2015 20072 20078
38. B. Zheng, J. van Bergenhenegouwen, H.J. van de Kant, G. Folkerts, J. Garssen, A.P. Vos, and et al. Specific probiotic dietary supplementation leads to different effects during remission and relapse in murine chronic colitis Benefic. Microbes 1-10 2015
39. E. Elinav, T. Waks, and Z. Eshhar Redirection of regulatory T cells with predetermined specificity for the treatment of experimental colitis in mice Gastroenterology 134 2008 2014 2024
40. E. Gonzalez-Rey, and M. Delgado Therapeutic treatment of experimental colitis with regulatory dendritic cells generated with vasoactive intestinal peptide Gastroenterology 131 2006 1799 1811
41. M. Boirivant, A. Amendola, A. Butera, M. Sanchez, L. Xu, M. Marinaro, and et al. A transient breach in the epithelial barrier leads to regulatory T-cell generation and resistance to experimental colitis Gastroenterology 135 2008 1612 1623 e5
42. M. Schultz, U.G. Strauch, H.J. Linde, S. Watzl, F. Obermeier, C. Gottl, and et al. Preventive effects of Escherichia coli strain Nissle 1917 on acute and chronic intestinal inflammation in two different murine models of colitis Clin. Diagn. Lab. Immunol. 11 2004 372 378
43. M. Oliveira, N. Bosco, G. Perruisseau, J. Nicolas, I. Segura-Roggero, S. Duboux, and et al. Lactobacillus paracasei reduces intestinal inflammation in adoptive transfer mouse model of experimental colitis Clin. Dev. Immunol. 2011 2011 807483
44. R. Chauhan, A.S. Vasanthakumari, H. Panwar, R.H. Mallapa, R.K. Duary, V.K. Batish, and et al. Amelioration of colitis in mouse model by exploring antioxidative potentials of an indigenous probiotic strain of Lactobacillus fermentum Lf1 BioMed research international. 2014 2014 206732
45. F. Hacini-Rachinel, S. Nancey, G. Boschetti, F. Sardi, R. Doucet-Ladeveze, P.Y. Durand, and et al. CD4 + T cells and Lactobacillus casei control relapsing colitis mediated by CD8 + T cells J. Immunol. 183 2009 5477 5486
46. I.D. Iliev, E. Mileti, G. Matteoli, M. Chieppa, and M. Rescigno Intestinal epithelial cells promote colitis-protective regulatory T-cell differentiation through dendritic cell conditioning Mucosal immunology. 2 2009 340 350
47. J.L. Coombes, K.R. Siddiqui, C.V. Arancibia-Carcamo, J. Hall, C.M. Sun, Y. Belkaid, and et al. A functionally specialized population of mucosal CD103 + DCs induces Foxp3 + regulatory T cells via a TGF-beta and retinoic acid-dependent mechanism The Journal of experimental medicine. 204 2007 1757 1764
48. S. Sakaguchi, K. Wing, Y. Onishi, P. Prieto-Martin, and T. Yamaguchi Regulatory T cells: how do they suppress immune responses? Int. Immunol. 21 2009 1105 1111
49. B. Zheng, J. van Bergenhenegouwen, S. Overbeek, H.J. van de Kant, J. Garssen, G. Folkerts, and et al. Bifidobacterium breve attenuates murine dextran sodium sulfate-induced colitis and increases regulatory T cell responses PLoS One 9 2014 e95441
50. H.M. Zhao, X.Y. Huang, Z.Q. Zuo, Q.H. Pan, M.Y. Ao, F. Zhou, and et al. Probiotics increase T regulatory cells and reduce severity of experimental colitis in mice World J. Gastroenterol. 19 2013 742 749
51. C. Reenaers, E. Louis, and J. Belaiche Current directions of biologic therapies in inflammatory bowel disease Ther. Adv. Gastroenterol. 3 2010 99 106
52. W. Strober, and I.J. Fuss Proinflammatory cytokines in the pathogenesis of inflammatory bowel diseases Gastroenterology 140 2011 1756 1767
53. X. Qiu, M. Zhang, X. Yang, N. Hong, and C. Yu Faecalibacterium prausnitzii upregulates regulatory T cells and anti-inflammatory cytokines in treating TNBS-induced colitis J. Crohn's Colitis 7 2013 e558 e568
54. N. Ueno, M. Fujiya, S. Segawa, T. Nata, K. Moriichi, H. Tanabe, and et al. Heat-killed body of Lactobacillus brevis SBC8803 ameliorates intestinal injury in a murine model of colitis by enhancing the intestinal barrier function Inflamm. Bowel Dis. 17 2011 2235 2250
55. L.X. Sang, B. Chang, C. Dai, N. Gao, W.X. Liu, and M. Jiang Heat-killed VSL#3 ameliorates dextran sulfate sodium (DSS)-induced acute experimental colitis in rats Int. J. Mol. Sci. 15 2014 15 28
56. H. Jijon, J. Backer, H. Diaz, H. Yeung, D. Thiel, C. McKaigney, and et al. DNA from probiotic bacteria modulates murine and human epithelial and immune function Gastroenterology 126 2004 1358 1373
57. E. Macho Fernandez, V. Valenti, C. Rockel, C. Hermann, B. Pot, I.G. Boneca, and et al. Anti-inflammatory capacity of selected lactobacilli in experimental colitis is driven by NOD2-mediated recognition of a specific peptidoglycan-derived muropeptide Gut 60 2011 1050 1059
58. S.G. Jeon, H. Kayama, Y. Ueda, T. Takahashi, T. Asahara, H. Tsuji, and et al. Probiotic Bifidobacterium breve induces IL-10-producing Tr1 cells in the colon PLoS Pathog. 8 2012 e1002714
59. A. Grabig, D. Paclik, C. Guzy, A. Dankof, D.C. Baumgart, J. Erckenbrecht, and et al. Escherichia coli strain Nissle 1917 ameliorates experimental colitis via toll-like receptor 2- and toll-like receptor 4-dependent pathways Infect. Immun. 74 2006 4075 4082
60. R. Saber, M. Zadeh, K.C. Pakanati, P. Bere, T. Klaenhammer, and M. Mohamadzadeh Lipoteichoic acid-deficient Lactobacillus acidophilus regulates downstream signals Immunotherapy 3 2011 337 347
61. S.P. Pandey, H.S. Chandel, S. Srivastava, S. Selvaraj, M.K. Jha, D. Shukla, and et al. Pegylated bisacycloxypropylcysteine, a diacylated lipopeptide ligand of TLR6, plays a host-protective role against experimental Leishmania major infection J. Immunol. 193 2014 3632 3643